Cannabis Bioscience International Holdings (CBIH) Revenue (2022 - 2025)
Historic Revenue for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to $24200.0.
- Cannabis Bioscience International Holdings' Revenue fell 8647.19% to $24200.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $148335.0, marking a year-over-year decrease of 5820.47%. This contributed to the annual value of $303022.0 for FY2025, which is 2177.33% up from last year.
- Cannabis Bioscience International Holdings' Revenue amounted to $24200.0 in Q3 2025, which was down 8647.19% from $34956.0 recorded in Q2 2025.
- In the past 5 years, Cannabis Bioscience International Holdings' Revenue registered a high of $178887.0 during Q3 2024, and its lowest value of $14931.0 during Q1 2025.
- For the 4-year period, Cannabis Bioscience International Holdings' Revenue averaged around $63025.8, with its median value being $57500.0 (2023).
- As far as peak fluctuations go, Cannabis Bioscience International Holdings' Revenue skyrocketed by 14565.3% in 2024, and later crashed by 8647.19% in 2025.
- Quarter analysis of 4 years shows Cannabis Bioscience International Holdings' Revenue stood at $82581.0 in 2022, then decreased by 22.81% to $63748.0 in 2023, then grew by 16.47% to $74248.0 in 2024, then crashed by 67.41% to $24200.0 in 2025.
- Its Revenue was $24200.0 in Q3 2025, compared to $34956.0 in Q2 2025 and $14931.0 in Q1 2025.